Drug factory · FDA FEI 1000522077

Packaging Coordinators, LLC

3001 Red Lion Rd, Philadelphia, PA, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 31, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2009: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AbrocitinibPackages it and labels it U.S. Pharmaceuticals 63539-236, 63539-336, 63539-436
AdalimumabPackages it Meitheal Pharmaceuticals Inc. 71288-815, 71288-816, 71288-817 +1
AfliberceptPackages it and labels it Regeneron Pharmaceuticals, Inc. 61755-005
AliskirenPackages it Noden Pharma USA, Inc. 70839-150, 70839-300
Bendroflumethiazide and NadololRepackages it Impax Generics 0115-5311, 0115-5322
BremelanotidePackages it Cosette Pharmaceuticals, Inc. 0713-0897
DeferoxaminePackages it Mitem Pharma 87081-467
DexamethasonePackages it and labels it Ocular Therapeutix, Inc. 70382-204
Efmoroctocog AlfaPackages it and labels it Bioverativ Therapeutics Inc. 71104-801, 71104-802, 71104-803 +7
Eftrenonacog AlfaPackages it and labels it Bioverativ Therapeutics Inc. 71104-911, 71104-922, 71104-933 +3
Interferon Beta-1aPackages it and labels it Biogen Inc. 59627-002, 59627-003
Interferon Beta-1a and Isopropyl AlcoholPackages it and labels it Biogen Inc. 59627-222, 59627-333
LerodalcibepLabels it LIB Therapeutics, Inc. 84685-300
LevoketoconazoleLabels it Xeris Pharmaceuticals, Inc. 72065-003
NaltrexonePackages it and labels it Alkermes, Inc. 65757-300, 65757-301
NirsevimabPackages it and labels it Sanofi Vaccines US Inc. 49281-574, 49281-575
OteseconazolePackages it and labels it Mycovia Pharmaceuticals, Inc. 74695-823
ParoxetinePackages it and labels it Legacy Pharma USA, Inc. 83107-027
PegcetacoplanPackages it Apellis Pharmaceuticals, Inc. 73606-020
RilonaceptPackages it Kiniksa Pharmaceuticals (UK), Ltd. 73604-914
UblituximabPackages it and labels it TG Therapeutics, Inc. 73150-150

FDA inspection history

EndedResultProgramProblems noted
Jan 31, 2025Problems found, fixed voluntarilyDrug Quality Assurance1
Jan 12, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 21, 2022Problems found, fixed voluntarilyDrug Quality Assurance2
Sep 6, 2017No problems foundDrug Quality Assurance—
Nov 25, 2013No problems foundDrug Quality Assurance—
Nov 4, 2009No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Jan 31, 2025 inspection

Oct 21, 2022 inspection

Registered with FDA for: label; pack; repack; sterilize.